Prof. Dr. Tanja Schneider
Institute for Pharmaceutical Microbiology
tschneider@uni-bonn.de View member: Prof. Dr. Tanja Schneider
International journal of molecular sciences
The rapid rise of multidrug-resistant (MDR) bacteria has once again caused bacterial infections to become a global health concern. Antimicrobial peptides (AMPs), also known as host defense peptides (HDPs), offer a viable solution to these pathogens due to their diverse mechanisms of actions, which include direct killing as well as immunomodulatory properties (e.g., anti-inflammatory activity). HDPs may hence provide a more robust treatment of bacterial infections. In this review, the advent of and the mechanisms that lead to antibiotic resistance will be described. HDP mechanisms of antibacterial and immunomodulatory action will be presented, with specific examples of how the HDP aurein 2.2 and a few of its derivatives, namely peptide 73 and cG4L73, function. Finally, resistance that may arise from a broader use of HDPs in a clinical setting and methods to improve biocompatibility will be briefly discussed.
PMID: 34681833
Institute for Pharmaceutical Microbiology
tschneider@uni-bonn.de View member: Prof. Dr. Tanja Schneider